Cure8 research brief
Why This Matters
A trained singer with Crohn's disease showed cyclical vocal changes tied to biologic infusion timing — this could affect quality of life and work for voice-dependent people with IBD.
Who Should Pay Attention
Adult patients with Crohn's disease (especially performers or professional voice users), clinicians managing IBD on biologics, and speech-language pathologists/voice specialists.
Study Snapshot
What To Know
The study followed one 18-year-old singer across nine sessions over a year, assessing voice via videostroboscopy, perceptual ratings, acoustic/aerodynamic measures, and the Singing Voice Handicap Index (SVHI).
Videostroboscopy and perceptual ratings showed clear pre-infusion worsening and post-infusion improvement, while objective acoustic and aerodynamic measures stayed within normative ranges and did not track the cycle.
Multimodal assessment is highlighted: highly trained voice users may report perceptual changes not captured by standard acoustic/aerodynamic metrics, so clinicians should consider laryngoscopic and patient-reported assessments when voice is a primary concern. Study limits: this is a single-case report, so findings are preliminary and may not generalize.
Keep In Mind
This is a single-case longitudinal study (one patient, nine sessions). Results suggest possible treatment-related timing effects on laryngeal signs and perceived voice handicap but do not prove cause-effect or apply broadly without further research.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.